Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Ownership [Axis] MDB Capital Holdings LLC [Member] Statistical Measurement [Axis] Minimum [Member] Legal Entity [Axis] Department of Energy [Member] NIH [Member] Product and Service [Axis] Grant [Member] Intangible Asset, Finite-Lived, Class [Axis] Patents [Member] Related and Nonrelated Parties [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Financial Instrument [Axis] Cash and Cash Equivalents [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Long-Lived Asset, Class [Axis] Laboratory Equipment [Member] Furniture and Fixtures [Member] Leasehold Improvements [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Subscription Agreement [Member] Funding Warrant [Member] Investor [Member] Private Warrant [Member] Maximum [Member] Underwriters [Member] Plan Name [Axis] 2020 Plan [Member] Award Type [Axis] 2025 Equity Incentive Plan [Member] Option Holders [Member] Exercise Price Range [Axis] Exercise Price One [Member] Exercise Price Two [Member] Restricted Stock Units (RSUs) [Member] Lock Up Agreement [Member] Share-Based Payment Arrangement, Option [Member] Antidilutive Securities [Axis] Warrant [Member] Licensed Product [Member] License Agreement [Member] Second Licensed Product [Member] Lease Agreement [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Public Venture LLC [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Cash and cash equivalents Grants receivable Prepaid expenses and other current assets Total current assets Property and equipment, net Operating lease right-of-use asset, net Finance lease right-of-use asset, net Tax receivable Total assets LIABILITIES AND EQUITY Accounts payable Due to affiliates Operating lease liabilities – Current Finance lease liabilities – Current Total current Liabilities Deferred grant reimbursement Operating lease liabilities - Long term Finance lease liabilities - Long term Total liabilities Stockholders’ Equity: Preferred stock, $0.000001 par value, 5,000,000 shares authorized; no shares issued and outstanding on March 31, 2026, and December 31, 2025, respectively. Common shares, 100,000,000 authorized shares at $0.000001; 8,478,992 and 8,406,681 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively Additional Paid-in-capital Accumulated deficit Total equity Total liabilities and equity Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, shares authorized Common stock, par value Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Total operating income Operating costs: General and administrative costs: Compensation Professional fees Information technology General and administrative-other Total general and administrative costs Research and development costs Total operating costs Net operating loss Other income/(expense): Interest income/ (expense), net Other income/(expense) Loss before income taxes Income tax expense Net loss Net loss per common share - basic Net loss per common share - diluted Weighted average of common shares outstanding - basic Weighted average of common shares outstanding - diluted Statement [Table] Statement [Line Items] Balance Balance, shares Stock based compensation Issuance of common stock due to vesting of RSU Issuance of common stock due to vesting of RSU, shares Issuance of Common stock for exercise of options Issuance of Common stock for exercise of options, shares Net loss Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities: Amortization of Deferred Grant Reimbursement Depreciation of property and equipment Non-cash lease expense Stock-based compensation Changes in operating assets and liabilities: Grants receivable Prepaid expenses and other current assets Accounts payable and accrued expenses Due to related party Net cash (used in) operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property and equipment Net cash (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Related Party Note Payments on finance lease obligations Net cash (used in) financing activities NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS - END OF PERIOD Supplemental disclosures of cash flow information: Interest Expense Accounting Policies [Abstract] Organization and Description of Business Summary of Significant Accounting Policies Equity [Abstract] Equity Stock-Based Compensation Earnings Per Share [Abstract] Earnings Per Share Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Retirement Benefits [Abstract] Employee Benefit Plans Exclusive License Agreement Exclusive License Agreement (eXoZymes) Leases Leases Income Tax Disclosure [Abstract] Income Taxes Subsequent Events [Abstract] Subsequent Events Basis of Presentation and Principles of Consolidation Use of Estimates Recent Accounting Pronouncements Emerging Growth Company Concentration of Risk Revenue Recognition Cash and Cash Equivalents Fair Value Measurements Property and Equipment Research Grants Research and Development Costs Patent and Licensing Legal and Filing Fees and Costs Related Party and Due to Affiliates Expenses Segment Reporting Schedule of Financial Instruments Measured at Fair Value on Recurring Basis Schedule of Property and Equipment Estimated Useful Lives Schedule of Property and Equipment Schedule of Grants Receivable Activity Schedule of Warrant Outstanding Issued Exercised and Expired Schedule of Stock Option Grants Schedule of Stock Options Activity Schedule of Restricted Stock Units Activity Schedule of Basic and Diluted Earnings (Loss) Per Share Schedule of Anti-dilutive Loss Per Share Schedule of Operating Leases Schedule of Future Payments Due Under Operating and Finance Leases Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Line Items] Minority ownership percentage Net losses Cash used for operations Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] Total fair value Estimated useful lives Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Total property and equipment Less: Accumulated depreciation Property and equipment, net Balance at beginning of period Grant costs expensed Grant fees Grant funds received Balance at end of period Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Grant reimbursements percentage FDIC insurance limit SIPC insurance limits Cash and unrestricted cash uninsured amount Grant awarded value Total grants value Grant drawdowns Grant drawdowns Research and development costs Legal fees Outstanding payable Number of reportable segment Number of warrants outstaning, Balance Weighted average exercise price, Balance Expiration date Number of warrants, Issued Number of warrants, Exercised Number of warrants, Expired Number of warrants outstaning, Balance Weighted average exercise price, Balance Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of shares issued Value of shares issued Warrants purchase price Warrants to purchase shares Warrants vested Value of warrants Shares issuable upon exercise of warrants Warrants exercise price Gross proceeds from private offering Proceeds from warrants exercise Warrants issued Warrants expiration term Shares Granted Exercise Price Vesting Term Expected Life Risk Free Rate Expected Volatility Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of Shares, Stock Options Outstanding, Balance Weighted Average Exercise Price Stock Options Outstanding, Balance Weighted Average Remaining Contractual Life, Stock Options Outstanding Number of Shares, Granted Weighted Average Exercise Price, Granted Weighted Average Remaining Contractual Life, Granted Number of Shares, Exercised Weighted Average Exercise Price, Exercised Weighted Average Remaining Contractual Life, Exercised Number of Shares, Expired Weighted Average Exercise Price, Expired Number of Shares, Forfeited/Cancelled Weighted Average Exercise Price, Forfeited/Cancelled Weighted Average Remaining Contractual Life, Forfeited/Cancelled Number of Shares, Stock Options Outstanding, Balance Weighted Average Exercise Price Stock Options Outstanding, Balance Number of Shares Stock options exercisable Outstanding Weighted Average Exercise Price, Exercisable Weighted Average Remaining Contractual Life, exercisable Number of Restricted Stock Units, Outstanding, Beginning Weighted Average Grant Date Fair Value, Outstanding, Beginning Weighted Average Remaining Contractual Life, Outstanding Number of Restricted Stock Units, Granted Weighted Average Grant Date Fair Value, Granted Number of Restricted Stock Units, Exercised Weighted Average Grant Date Fair Value, Exercised Weighted Average Remaining Contractual Life, Expired Number of Restricted Stock Units, Forfeited Weighted Average Grant Date Fair Value, Forfeited Number of Restricted Stock Units, Outstanding, Ending Weighted Average Grant Date Fair Value, Outstanding, Ending Number of Restricted Stock Units, Unvested Weighted Average Grant Date Fair Value, Unvested Weighted Average Remaining Contractual Life, Unvested Shares authorized for issuance Weighted average remaining contractual term Dividend yield Stock options, exercised Exercise price Shares withheld Shares issued upon exercise Unvested options outstanding Exercise price of options exercised Stock option vested Stock option exercise price Stock option intrinsic value Vesting period Stock option expiration term Unrecognized stock-based compensation Restricted stock units, granted Restricted stock units per price Expiration date Unrecognized stock-based compensation Weighted average remaining life, exercisable Restricted stock units [custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod] Weighted average shares outstanding - basic Net loss per share - basic Net loss per share - diluted Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total Antidilutive securities, shares Post employment benefit ExclusiveLicenseAgreementTable [Table] Payment for licensed product Cumulative net sales Payments for patent fees License fees paid Schedule Of Operating Leases Right-of-use assets Operating lease liabilities Weighted average remaining lease term in years Weighted average discount rate Cash paid for amounts included in the measurement of lease liabilities Right-of-use assets obtained in exchange for lease liabilities Right-of-use assets Finance lease liabilities Weighted average remaining lease term in years Weighted average discount rate Amortization of assets under finance lease Interest Schedule Of Future Payments Due Under Operating And Finance Leases Operating Lease 2025 Operating Leases 2026 Operating Leases 2027 Operating Leases 2028 Operating Leases Total Operating Leases Less effects of discounting Operating Leases Total operating lease liabilities Financial Lease 2025 Finance Leases 2026 Finance Leases 2027 Finance Leases 2028 Finance Leases Total Finance Leases Less effects of discounting Finance Leases Total Finance Leases liabilities Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Variable lease cost Operating lease term Rent per month Base rent paid in final year Operating cost percenatge Current lease Current leased space amount Rent per month in final year Current lease in final year Current leased space amount in final year Fair value of lease equipment Assumed rate percentage Present value of assets Percentage of assets fair value Operating lease cost Finance lease payments Effective tax rate Federal statutory rate Federal income tax returns Subsequent Event [Table] Subsequent Event [Line Items] Public offering Proceeds from deferred grant reimbursement. Emerging Growth Company [Policy Text Block] Department of Energy [Member] NIH [Member] Cash SIPC insured amount. Schedule of Property Plant and Equipment Estimated Useful Lives [Table Text Block] Laboratory Equipment [Member] Research Grants [Policy Text Block] Schedule Of Grants Receivable [Table Text Block] Grant drawdowns. Research and development costs. Related Party Expenses [Policy Text Block] MDB Capital Holdings LLC [Member] SubscriptionAgreementMember Funding Warrant [Member] Share based payment award nonoption vested number of shares. Private Warrant [Member] Warrants expiration term. 2020 Plan [Member] 2025 Equity Incentive Plan [Member] Share based compensation arrangement by share based payment award options granted weighted average remaining contractual term 2. Share based compensation arrangement by share based payment award equity instrument other than options expired weighted average remaining contractual terms. Share based compensation arrangement by share based payment award equity instruments other than options exercised in period. Share based compensation arrangement by share based payment award equity instruments other than options expired in period weighted average grant date fair value. The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. Share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average remaining contractual expired terms. Share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average remaining contractual terms. Exclusive License Agreement Disclosure [Text Block] Payments to acquire licensed product. Licensed Product [Member] License Agreement [Member] Cumulative net sales. Second Licensed Product [Member] Payment for license fees. Base rent paid in final year. Lease Agreement [Member] Operating cost percenatge. Payments for rent in final year. Current leased space amount in final year. Current lease in final year. Current leased space amount. Percentage of assets fair value. Public Venture LLC [Member] Grant costs expensed. Grants for equipment purchased. Grant fees. Grant funds received. Government grant reimbursements percentage. Grant awarded value. Grants value. Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. Underwriters [Member] Key Executives [Member] Shareholder [Member] Option Holders [Member] Two Option Holders [Member] Exercise Price One [Member] Exercise Price Two [Member] Share based compensation arrangement by share based payment award equity instruments other than options non vested. Share based compensation arrangement by share based payment award options forfeited and cancelled weighted average remaining contractual term. Share based compensation arrangement by share based payment award options exercised weighted average remaining contractual term. Lock Up Agreement [Member] Useful Life, Shorter of Lease Term or Asset Utility [Member] Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity General and Administrative Expense Operating Costs and Expenses Operating Income (Loss) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense and Other Assets Payments to Acquire Property, Plant, and Equipment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Lessee, Operating Leases [Text Block] Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization ResearchAndDevelopmentCosts Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Finance Lease, Weighted Average Remaining Lease Term Finance Lease, Weighted Average Discount Rate, Percent Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Finance Lease, Liability, to be Paid Finance Lease, Liability, Undiscounted Excess Amount